新辅助化疗方案对乳腺癌的治疗效果探讨
详细信息 查看官网全文
- 论文作者：李全民
- 年：2016
- 作者机构：河北省宽城满族自治县医院肿瘤科;
- 论文关键词：新辅助化疗 ; 乳腺癌 ; 治疗
- 英文论文关键词：neoadjuvant chemotherapy ; breast cancer ; treatment
- 会议召开时间：2016-11-25
- 会议录名称：湖南中医药大学学报2016/专集：国际数字医学会数字中医药分会成立大会暨首届数字中医药学术交流会论文集
- 语种：中文
- 分类号：R737.9
- 学会代码：HNZY
- 会议名称：国际数字医学会数字中医药分会成立大会暨首届数字中医药学术交流会
- 会议地点：中国广东珠海
- 主办单位：国际数字医学会、Digital Chinese Medicine
- 学会名称：湖南中医药大学期刊杂志社
- 页数：2
- 文件大小：1849k
- 原文格式：D
- 会议级别：全国
摘要
目的对应用新辅助化疗方案对患有乳腺癌疾病的患者实施治疗的临床效果进行研究。方法选择我院收治的患有乳腺癌疾病的患者76例,随机分为对照组和治疗组,平均每组38例。采用常规化疗方案对对照组患者实施治疗;采用新辅助化疗方案对治疗组患者实施治疗。结果治疗组患者乳腺癌疾病的化疗总有效率明显高于对照组;在化疗期间出现的不良反应例数明显少于对照组;乳腺癌疾病症状消失时间和化疗计划实施总时间明显短于对照组。结论应用新辅助化疗方案对患有乳腺癌疾病的患者实施治疗的临床效果非常明显。
Objective To study the clinical effect of neoadjuvant chemotherapy in the treatment of breast cancer patients. Methods 76 patients with breast cancer in our hospital wererandomly divided into the control group and the treatment group, with an average of 38 cases in each group. The control group was treated with conventional chemotherapy, and the treatment groupwas treated with neoadjuvant chemotherapy. Results The treatment group patients with breast cancer chemotherapy, the total efficiency was significantly higher than the control group; the numberof cases of adverse reactions occurred during chemotherapy was significantly lower than the control group; the disease symptoms of breast cancer and chemotherapy plan disappeared time wasshorter than the control group. Conclusions The clinical effect of neoadjuvant chemotherapy on patients with breast cancer is very obvious.
Objective To study the clinical effect of neoadjuvant chemotherapy in the treatment of breast cancer patients. Methods 76 patients with breast cancer in our hospital wererandomly divided into the control group and the treatment group, with an average of 38 cases in each group. The control group was treated with conventional chemotherapy, and the treatment groupwas treated with neoadjuvant chemotherapy. Results The treatment group patients with breast cancer chemotherapy, the total efficiency was significantly higher than the control group; the numberof cases of adverse reactions occurred during chemotherapy was significantly lower than the control group; the disease symptoms of breast cancer and chemotherapy plan disappeared time wasshorter than the control group. Conclusions The clinical effect of neoadjuvant chemotherapy on patients with breast cancer is very obvious.
引文
[1]袁业伟,孙治君.三阴性乳腺癌最新治疗及研究进展[J].重庆医学,2015,44(16):2279-2280.
[2]郭士婷,宋晨,赵金波.三阴性乳腺癌的临床病理特点与预后因素分析[J].医学与哲学,2015,36(24):50-51.
[3]陈曲,哈敏文,包翠芬.BRCA-1在三阴性乳腺癌中的表达及意义[J].数理医药学杂志,2012,25(5):513-514.
[4]丁淑云,袁斌,王欣,等.BRCA1/2基因相关乳腺癌临床用药进展[J].中国新药与临床杂志,2015,34(3):166-167.
[5]唐小飞,董志,傅洁民,等.卡铂联合PF-04691502抗三阴性乳腺癌细胞的体外研究[J].第三军医大学学报,2013,35(5):442-443.
[6]屈海鸥,郑志坚,李小雷.紫杉醇脂质体联合卡铂治疗耐药三阴性乳腺癌的临床研究[J].全科医学临床与教育,2014,12(6):623-624.
[2]郭士婷,宋晨,赵金波.三阴性乳腺癌的临床病理特点与预后因素分析[J].医学与哲学,2015,36(24):50-51.
[3]陈曲,哈敏文,包翠芬.BRCA-1在三阴性乳腺癌中的表达及意义[J].数理医药学杂志,2012,25(5):513-514.
[4]丁淑云,袁斌,王欣,等.BRCA1/2基因相关乳腺癌临床用药进展[J].中国新药与临床杂志,2015,34(3):166-167.
[5]唐小飞,董志,傅洁民,等.卡铂联合PF-04691502抗三阴性乳腺癌细胞的体外研究[J].第三军医大学学报,2013,35(5):442-443.
[6]屈海鸥,郑志坚,李小雷.紫杉醇脂质体联合卡铂治疗耐药三阴性乳腺癌的临床研究[J].全科医学临床与教育,2014,12(6):623-624.